UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000031894
Receipt No. R000036404
Scientific Title Cumulative network-meta-analyses, practice guidelines and real-world prescriptions of drug treatments for post-menopausal osteoporosis
Date of disclosure of the study information 2018/04/01
Last modified on 2018/12/07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Cumulative network-meta-analyses, practice guidelines and real-world prescriptions of drug treatments for post-menopausal osteoporosis
Acronym Cumulative network-meta-analyses, practice guidelines and real-world prescription
Scientific Title Cumulative network-meta-analyses, practice guidelines and real-world prescriptions of drug treatments for post-menopausal osteoporosis
Scientific Title:Acronym Cumulative network-meta-analyses, practice guidelines and real-world prescription
Region
Japan North America Europe

Condition
Condition post-menopausal osteoporosis
Classification by specialty
Medicine in general Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study aims to compare the results of cumulative NMAs with the recommendations in post-menopausal osteoporosis practice guidelines, and with the actual prescription practices.
Basic objectives2 Others
Basic objectives -Others not applicable
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Ranking of drugs to treat post-menopausal osteoporosis by means of cumulative network meta-analysis. Ranking of recommended post-menopausal osteoporosis in clinical practice guidelines in America. Ranking of actual prescriptions based on MEPS.
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
50 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria post-menopausal osteoporois
Key exclusion criteria Rheumatoid arthritis and related disease
Chronic renal failure
Cancer
Target sample size 500

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Toshi A Furukawa
Organization Kyoto University Graduate School of Medicine
Division name Department of Health Promotion and Human Behavior, School of Public Health
Zip code
Address Floor 2, G Buiding, Kyoto University Graduate School of Medicine, Yoshida Konoe-cho, Sakyo-ku, Kyoto, JAPAN
TEL +81-75-753-9491
Email furukawa@kuhp.kyoto-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Yuki Kataoka
Organization Hyogo Prefectural Amagasaki General Medical Center
Division name Hospital Care Research Unit
Zip code
Address 2-17-77 Higashi-Naniwa-Cho, Amagasaki, Hyogo 660-8550, Japan
TEL +81664807000
Homepage URL
Email youkiti@gmail.com

Sponsor
Institute Department of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine
Institute
Department

Funding Source
Organization JSPS Grant-in-Aid for Scientific Research (Grant Number17k19808)
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 04 Month 01 Day

Related information
URL releasing protocol https://bmjopen.bmj.com/content/8/12/e023218
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2018 Year 12 Month 03 Day
Date of IRB
Anticipated trial start date
2018 Year 12 Month 03 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
2020 Year 03 Month 31 Day

Other
Other related information It is an epi-epidemiologic research based on cumulative network meta-analysis and open data.

Management information
Registered date
2018 Year 03 Month 26 Day
Last modified on
2018 Year 12 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036404

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.